相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Valerie Cortez et al.
BREAST CANCER RESEARCH (2012)
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor
Daisuke Ogasawara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human LSD2/KDM1b/AOF1 Regulates Gene Transcription by Modulating Intragenic H3K4me2 Methylation
Rui Fang et al.
MOLECULAR CELL (2010)
Histone demethylases in development and disease
Marianne Terndrup Pedersen et al.
TRENDS IN CELL BIOLOGY (2010)
Histone modifying enzymes: Structures, mechanisms, and specificities
Ronen Marmorstein et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
Johannes H. Schulte et al.
CANCER RESEARCH (2009)
A Novel Mammalian Flavin-dependent Histone Demethylase
Aristotele Karytinos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Rie Ueda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints
David N. Ciccone et al.
NATURE (2009)
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Jing Wang et al.
NATURE GENETICS (2009)
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells
Pierre-Olivier Esteve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors
Markus Heidenblad et al.
BMC MEDICAL GENOMICS (2008)
Comparative analysis of human chromosome 7q21 and mouse proximal chromosome 6 reveals a placental-specific imprinted gene, TFPI2/Tfpi2, which requires EHMT2 and EED for allelic-silencing
David Monk et al.
GENOME RESEARCH (2008)
Histone lysine demethylases: emerging roles in development, physiology and disease
Yang Shi
NATURE REVIEWS GENETICS (2007)
The complex language of chromatin regulation during transcription
Shelley L. Berger
NATURE (2007)
trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1
Dawn M. Z. Schmidt et al.
BIOCHEMISTRY (2007)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells
SD Konduri et al.
ONCOGENE (2003)
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells
F Hubé et al.
BIOLOGICAL CHEMISTRY (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2
SS Lakka et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
分享论文
